Viewing nowLipido Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Genupharm Co., Ltd.

MFDS item code 201501979 · Approved 2015.04.10 · Insurance code 698002830
Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular diseases
This medication helps reduce the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction and stroke in adults aged 55 and over, or those with several risk factors such as smoking, hypertension, and low HDL-cholesterol levels. Additionally, it lowers the risk related to coronary artery disease, vascular interventions, and chronic stable angina. Diabetic patients with cardiovascular risk factors also benefit from the reduction of myocardial infarction and stroke risks. Patients with pre-existing coronary artery disease experience reduced rates of fatal and non-fatal strokes, myocardial infarctions, hospitalizations due to congestive heart failure, and angina. Furthermore, in the treatment of hyperlipidemia, it effectively lowers cholesterol and triglyceride levels while increasing HDL-cholesterol levels, thereby improving health. It is also used to reduce total cholesterol and LDL-cholesterol levels in pediatric and adolescent patients with familial hypercholesterolemia.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. It may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, measurement of LDL cholesterol is recommended when initiating treatment and evaluating response. If LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia This drug is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients 70 years of age or older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses greater than 20 mg of this drug in pediatric patients).
This medication may cause muscle-related symptoms; therefore, if severe muscle pain or weakness occurs, you should discontinue use immediately and consult a physician. In particular, treatment should be discontinued if there is a significant increase in muscle enzyme levels or if myopathy is suspected. Patients with liver dysfunction or liver enzyme levels exceeding three times the upper limit of normal should not use this medication. Women who are pregnant or may become pregnant, as well as nursing mothers, should not use this medication. Children under 10 years old should not be given this drug, and safety and efficacy have not been fully established in children aged 10 to 17 years. Caution should be taken in patients with a history of alcohol dependence or liver disease. Elderly patients and those with decreased kidney function are at higher risk for myopathy, so they require careful monitoring. There are many drug interactions, especially with certain antibiotics, antifungals, and antivirals, so caution is advised when used in combination. Consumption of grapefruit juice may increase the blood concentration of this drug, so excessive intake should be avoided. It is important to regularly monitor liver function and muscle-related tests while taking this medication. Also, if severe skin rashes or allergic reactions occur, you should stop taking it immediately and inform your healthcare provider. Appropriate contraceptive methods should be used while taking this drug, and if pregnancy is confirmed, the drug should be discontinued. There is no specific antidote for overdose; treatment should be symptomatic, and blood tests may be necessary to monitor the patient's condition. This medication should be kept out of reach of children and stored securely in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to preserve the effectiveness of the drug.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Genupharm Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.